In European acute care hospitals, on any given day, an estimated 80,000 patients – roughly six percent of all patients – receive antimicrobial treatment to fight a healthcare associated infection (HAI), according to the European Centre for Disease Prevention and Control (ECDC). Report: Walter Depner
The USA’s President Barack Obama released a comprehensive plan in March to slow the emergence of drug-resistant bacteria, a multi-year, billion-dollar effort that includes getting doctors to stop over-prescribing antibiotics, developing new medications and rapid diagnostics, and real-time tracking of infection outbreaks. Report: Lisa Chamoff
Hospital-based pathologists may soon gain a new diagnostic assay that could prove effective in detecting hospital-acquired infections more quickly and more accurately than with existing rapid molecular diagnostic tests
They call him Mr Clean Hand. Professor Didier Pittet MD, Specialist in Infection Prevention and Control at the Hôpitaux Universitaires de Genève and Head of the Clean Care is Safer Care programme of the World Health Organisation (WHO), is known as the ‘Father of Modern Hand Hygiene’. Report: Michael Krassnitzer
A newly launched test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. The Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay was launched by EKF Diagnostics, based in Cardiff, Wales, which explains: ‘Procalcitonin is a marker for bacterial infection and sepsis and has been recognised as…
A group of leading scientists has warned that Britain and Europe collectively could face more than a million deaths in an impending "Antibiotic Armageddon” unless more is spent on developing new cures, rapid diagnostics and preventative measures to combat the spread of drug resistant diseases.
Curetis AG, a developer of next-level molecular diagnostic solutions, announced the successful completion of the clinical and analytical CE performance evaluation of its next-generation Unyvero P55 Pneumonia Application. The upgraded cartridge will launch at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID, April 25 – 28, 2015 in Copenhagen, Denmark) and is…
Leading infectious diseases experts have released new guidance for healthcare facilities looking to establish precautions for visitors of patients with infectious diseases. The guidance looks to reduce the potential for healthcare visitors in spreading dangerous bacteria within the healthcare facility and community. The recommendations are published online in Infection Control & Hospital…
30 years after HIV was discovered to be the cause of the acquired immune deficiency syndrome AIDS, and despite intensive research, no vaccine or cure has yet been found. An international team of scientists, in collaboration with the German Center for Infection Research (DZIF) and the University Hospital of Cologne, has now tested a new generation of antibodies in humans for the first time. They…
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) announces that the globe’s most prominent infection specialists will be gathering in Copenhagen to explore solutions to the biggest infection problems during its annual congress – the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) taking place on 25-28 April 2015.
A new "lab-on-a-disc" technology developed by an EU project research team can diagnose malaria and other febrile infectious diseases simultaneously in just an hour - allowing faster point-of-care treatment and precise drugs administration that could save thousands of lives.
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
A new CE-IVD certified molecular test has been added to Greiner Bio-One’s Genspeed test portfolio for nosocomial infections. In addition to the recently introduced MRSA test, the Genspeed C.diff OneStep test addresses the international need to combat Clostridium difficile (C. diff) infections. The test is analysed on the Genspeed R2 Analyser.
The European Society for Clinical Microbiology and Infectious Diseases (ESCMID) has been joined by the World Health Organisation (WHO) to launch the 7th annual ‘International Day for Fighting Infection’ (April 24th, 2015). This year’s event sees the European society exploring vaccines as a possible solution in the global, cross-border fight against antimicrobial resistance.
The ‘Robert Koch’ plane for medical evacuations (MedEvac) is the winged equivalent of a German hospital isolation ward. Within it, medics with viral haemorrhagic fever while working on the Ebola outbreak in West Africa, receive intensive medical care during any stages of the disease, while being evacuated. Report: Anja Behringer
Taking antibiotics for diarrhea may put travelers visiting developing parts of the world at higher risk for contracting superbugs and spreading these daunting drug-resistant bacteria to their home countries, according to a new study published in Clinical Infectious Diseases and now available online.
At the International Meeting on Emerging Diseases and Surveillance (IMED 2014), in Vienna, this year’s focus was on one particular emerging infectious disease: Ebola. According to the World Health Organisation (WHO), as of January 14th, more than 8.400 people have died of this dangerous disease and more than 21.000 cases were reported in nine countries. Report: Michael Krassnitzer
Scientists have discovered a new antibiotic, teixobactin, that can kill serious infections in mice without encountering any detectable resistance, offering a potential new way to get ahead of dangerous evolving superbugs.
On 29 July, Dr James Ritchie was attending the American Association of Clinical Chemistry’s annual conference in Chicago when he received the call that a physician and missionary worker, who had been in West Africa, were headed to Atlanta’s Emory University Hospital. Report: Lisa Chamoff
Early diagnosis and effective therapy of periprosthetic joint infections (PJI) remain a challenge for many physicians due to the complexity and heterogeneity of clinical symptoms. As individual solutions are needed, opportunities to discuss and exchange ideas are welcome, as clearly shown during the satellite symposium on the diagnosis and treatment of periprosthetic knee infections held at this…
Prosthetic joint infections (PJI) are the most frequent complication in orthopaedic implant patients and may occur any time: weeks, months, or even years after an implantation. Report: Ludger Weß
A new extracorporeal nanotech device addresses the root cause of sepsis by removing pathogens and endotoxins simultaneously from blood even before their identification – this genetically engineered mannose-binding lectin protein can also latch on to the Ebola virus... Report: Cynthia E Keen
A new study concludes that jet air and warm air hand driers have a greater potential to contaminate washrooms by spreading bacteria into the air and onto users and bystanders. The findings have significant implications for infection control health professionals and purchasing managers responsible for equipping hospital washrooms.
DNA Electronics (‘DNAe’), the inventors of semiconductor DNA sequencing technology and developers of a new point-of-need test for blood infections, highlights the urgent need for fast diagnostics to help tackle the growing threat of antibiotic resistance.
With an estimated fatality rate of 52%, the need to discover a cure for Ebola has never been more urgent. New research published in Journal of Biomolecular Structure and Dynamics this month suggests that scientists currently investigating potential cures for the Ebola virus should focus more attention on the protein furin.